ARN-4026

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameARN-4026
Drug Alias NameARN-4026 seriesATP competitive kinase inhibitor (Arrien Pharmaceuticals)ARN-4026
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase Tec modulators
TargetsTyrosine-protein kinase Tec
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArrien Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArrien Pharmaceuticals Llc
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A